Home The Word Brain	My Amedeo FAQ Privacy About
	Chinese Coaching Already know some Chinese? Stay on track with structured, one-on-one coaching to make steady, long-term progress. By Meng Wu and BSK.

Neoplasms of the CNS

Free Subscription 26.01.2026 1 Acta Neuropathol 1 BMC Cancer 3 Cancer Res 3 Childs Nerv Syst 1 Eur J Cancer 1 Int J Radiat Oncol Biol Phys 4 J Clin Oncol 9 J Neurooncol 1 J Neuropathol Exp Neurol 12 J Neurosurg 2 Neuro Oncol 1 Neuroradiology 1 Neurosurgery 2 PLoS Comput Biol

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Acta Neuropathol

1. BRAND F, Rose LS, Akbarzadeh AH, Weber CAM, et al
   Germline variants in ATM, BRCA2, other cancer predisposition and novel candidate genes are implicated in glioma risk in adult glioma patients with a familial or personal history of tumors.
   Acta Neuropathol. 2026;151:6.
   PubMed         Abstract available
   
   

   
   BMC Cancer

2. LI Y, Duan Y, Su Y, Zheng Z, et al
   Construction and internal assessment of an exploratory risk prediction model for psychological distress in brain tumor patients: a cross-sectional study.
   BMC Cancer. 2026 Jan 22. doi: 10.1186/s12885-026-15549.
   PubMed        
   
   

   
   Cancer Res

3. NAH GSS, Chong YK, Sulaimi FN, Lee KL, et al
   ETC-501 is a Brain Penetrant MNK Kinase Inhibitor that Potentiates TMZ-Induced Senescence and Sensitizes Glioblastoma Cells to Senolytic Therapy.
   Cancer Res. 2026 Jan 22. doi: 10.1158/0008-5472.CAN-24-4388.
   PubMed         Abstract available
   
   
4. KREGER BT, Liang Y, Reilly NM, Spears ME, et al
   CFT1946 Is an Orally Available Brain-Penetrant BRAFV600-Mutant Degrader That Overcomes BRAF Inhibitor Resistance.
   Cancer Res. 2026;86:438-452.
   PubMed         Abstract available
   
   
5. SCHUFTAN E, Lu IN, de Faria FW, Inserte C, et al
   Integrated Single-Nucleus and Spatial Transcriptomics Elucidate Heterogeneity and Hypoxia-Driven Organization of Supratentorial Ependymoma.
   Cancer Res. 2026;86:540-555.
   PubMed         Abstract available
   
   

   
   Childs Nerv Syst

6. SHEEN KWEH BT, Champion B, Dyke J, Lakshmanan R, et al
   Giant cystic choroid plexus papilloma mimicking intracerebral hydatid cyst.
   Childs Nerv Syst. 2026;42:37.
   PubMed         Abstract available
   
   
7. SALMAN A, Fahim MAA, Sohail A, Bashir HH, et al
   Pre-operative and intra-operative risk factors of post-operative cerebellar mutism syndrome in pediatric patients undergoing posterior fossa tumor surgery: a systematic review.
   Childs Nerv Syst. 2026;42:36.
   PubMed         Abstract available
   
   
8. HOGG F, Tucker S, Harris M, Tahir MZ, et al
   Spinal deformity following surgery for paediatric intramedullary spinal cord tumours.
   Childs Nerv Syst. 2026;42:33.
   PubMed         Abstract available
   
   

   
   Eur J Cancer

9. LE RHUN E, Sain D, van den Bent M, Franceschi E, et al
   Association of proton pump inhibitor use with outcome of patients with recurrent glioblastoma.
   Eur J Cancer. 2026;235:116225.
   PubMed         Abstract available
   
   

   
   Int J Radiat Oncol Biol Phys

10. COUPEY J, Pham TN, Toutain J, Ivanova V, et al
    Proton radiotherapy offers immune-sparing benefits in glioblastoma treatment Proton therapy reduced radiation-induced lymphopenia.
    Int J Radiat Oncol Biol Phys. 2026 Jan 15:S0360-3016(26)00010.
    PubMed         Abstract available
    
    

    
    J Clin Oncol

11. RUSTHOVEN CG, Serizawa T, Yamamoto M
    Radiosurgery for Small Cell Lung Cancer Brain Metastases: Comparing the JLGK0901 and BWH/DFCI Trials.
    J Clin Oncol. 2026 Jan 20:JCO2501794. doi: 10.1200/JCO-25-01794.
    PubMed        
    
    
12. NOGUCHI M, Nimura K, Koide Y
    Expanding Indications for Stereotactic Radiosurgery in Small Cell Lung Cancer With Brain Metastases.
    J Clin Oncol. 2026 Jan 20:JCO2501867. doi: 10.1200/JCO-25-01867.
    PubMed        
    
    
13. AKDOGAN O, Canaslan K, Hamitoglu B, Yazici O, et al
    Limitations in Study Design and Stratification in Phase II Stereotactic Radiosurgery Trial for Small Cell Lung Cancer Brain Metastases.
    J Clin Oncol. 2026 Jan 20:JCO2501729. doi: 10.1200/JCO-25-01729.
    PubMed        
    
    
14. AIZER AA, Catalano PJ, Rahman R
    Reply to: "Limitations in Study Design and Stratification in Phase II Stereotactic Radiosurgery Trial for Small Cell Lung Cancer Brain Metastases," "Radiosurgery for Small Cell Lung Cancer Brain Metastases: Comparing the JLGK0901 and BWH/DFCI Trials,"
    J Clin Oncol. 2026 Jan 20:JCO2502528. doi: 10.1200/JCO-25-02528.
    PubMed        
    
    

    
    J Neurooncol

15. CHEN SH, Wang HN, Toh CH, Wei KC, et al
    PET RANO 1.0 criteria improve prognostic stratification in high-grade gliomas using (11)C-methionine PET/MR.
    J Neurooncol. 2026;176:180.
    PubMed        
    
    
16. CIOFFI G, Waite K, Baranova A, Barnholtz-Sloan JS, et al
    Individualized prediction of brain metastasis risk in patients with breast cancer.
    J Neurooncol. 2026;176:179.
    PubMed        
    
    
17. BEKELMAN NJ, Ghaith AK, Yang L, Momeni A, et al
    Rates of recurrence and symptom improvement following resection of spinal meningiomas in the pediatric population: individual participant data meta-analysis.
    J Neurooncol. 2026;176:178.
    PubMed         Abstract available
    
    
18. PATEL SH, Mayorov S, Kim W, Singh K, et al
    Magnetic resonance imaging features differentiate histologic and molecular subtypes of glioblastoma IDH-Wild type CNS WHO grade 4.
    J Neurooncol. 2026;176:177.
    PubMed         Abstract available
    
    
19. BHANDARKAR S, Palermo M, Wu C, Myneni S, et al
    Profiling T-cell activity and exclusion in pediatric medulloblastoma highlights immunotherapy-responsive subgroups.
    J Neurooncol. 2026;176:176.
    PubMed        
    
    
20. MINNITI G, Tini P, Navarria P, Raza G, et al
    Clinical outcomes of three-fraction versus five-fraction stereotactic radiosurgery for resected brain metastases.
    J Neurooncol. 2026;176:175.
    PubMed         Abstract available
    
    
21. MORAES FY, Isen J, Perry J, Laperriere N, et al
    Nomograms for predicting survival of elderly patients with newly diagnosed glioblastoma: a secondary analysis of the CCTG CE.6 trial.
    J Neurooncol. 2026;176:171.
    PubMed        
    
    
22. NOBRE L, Ramaswamy V, Coleman C, Dhall G, et al
    High-dose chemotherapy and craniospinal irradiation-sparing approach for WNT medulloblastoma of early childhood.
    J Neurooncol. 2026;176:172.
    PubMed        
    
    
23. GENSLER R, Ahmed AK, Alfonzo Horowitz M, Khalifeh JM, et al
    Differences in regional developmental origins of glioblastomas revealed by integrated molecular profiling.
    J Neurooncol. 2026;176:170.
    PubMed        
    
    

    
    J Neuropathol Exp Neurol

24. YUAN J, Liu H, Wen J, Zhao Z, et al
    Cardiotrophin-like cytokine factor 1 regulated by Sry-related HMG-box transcription factor 9 promotes malignant behavior and immune evasion of glioblastoma multiforme.
    J Neuropathol Exp Neurol. 2026 Jan 19:nlaf161. doi: 10.1093.
    PubMed         Abstract available
    
    

    
    J Neurosurg

25. HALABIAN N, Hazrati R, Renaud MR, Ahmed A, et al
    Development of brain tumor banks as part of building neuro-oncological care systems in low- and middle-income countries.
    J Neurosurg. 2026 Jan 23:1-6. doi: 10.3171/2025.9.JNS251425.
    PubMed        
    
    
26. WONG CE, Chang Y, Huang YT, Hsu HJ, et al
    Impact of preoperative sinusitis on surgical outcomes in patients with pituitary adenoma undergoing endoscopic transsphenoidal surgery: a real-world population-based cohort study.
    J Neurosurg. 2025 Aug 8:1-9. doi: 10.3171/2025.4.JNS243094.
    PubMed         Abstract available
    
    
27. PHAM J, Gomez D, Shah I, Prasad A, et al
    Association between facility volume with treatment patterns and short-term surgical outcomes in pituitary adenoma: a National Cancer Database analysis.
    J Neurosurg. 2025;144:178-189.
    PubMed         Abstract available
    
    
28. ORDONEZ-CURE S, Uparela-Reyes MJ, Cardona-Collazos S, Fernandez-Osorio AD, et al
    Prolactinomas and Knosp grade: when is surgery the appropriate choice? A systematic review and meta-analysis.
    J Neurosurg. 2025;144:159-168.
    PubMed         Abstract available
    
    
29. CONSTANTHIN PE, Montalibet V, Quang ML, Ollivier M, et al
    Volumetric courses of the intraosseous and meningeal components of osteomeningiomas after cyproterone acetate treatment withdrawal.
    J Neurosurg. 2025;144:151-158.
    PubMed         Abstract available
    
    
30. SHINYA Y, Herndon JS, Palit SR, Hong S, et al
    Preoperative serum prolactin as a predictor of endocrine outcomes in nonfunctioning pituitary adenoma surgery: revisiting the "stalk effect".
    J Neurosurg. 2025;144:190-199.
    PubMed         Abstract available
    
    
31. DABBAGH OHADI MA, Soleimani S, Kakoienejad MM, Ghasemi M, et al
    Clinical benefits of photodynamic therapy in glioblastoma: systematic review and meta-analysis.
    J Neurosurg. 2026 Jan 16:1-11. doi: 10.3171/2025.8.JNS25763.
    PubMed         Abstract available
    
    
32. GHARIBI LORON A, Chow WD, Pumford AD, Zhao CY, et al
    Prognostic factors for 90-day survival after stereotactic radiosurgery for brain metastasis patients.
    J Neurosurg. 2026 Jan 9:1-9. doi: 10.3171/2025.8.JNS25859.
    PubMed         Abstract available
    
    
33. SHASBY G
    Erratum. Surgical site infection after cranioplasty for brain tumor: insights from a 15-year Swedish multicenter cohort.
    J Neurosurg. 2026 Jan 9:1. doi: 10.3171/2025.12.JNS251301.
    PubMed        
    
    
34. CAI K, Zhu H, Qiao N, Liu F, et al
    Endoscopic endonasal approach for craniopharyngioma resection in 604 cases: tumor classification, treatment strategies, and surgical outcomes.
    J Neurosurg. 2025 Dec 26:1-14. doi: 10.3171/2025.8.JNS251041.
    PubMed         Abstract available
    
    
35. BAO Y, Fu J, Gao Z, Shen D, et al
    Surgical management of giant craniopharyngiomas: expanded endoscopic endonasal or transcranial approach?
    J Neurosurg. 2025 Dec 12:1-12. doi: 10.3171/2025.8.JNS25138.
    PubMed         Abstract available
    
    
36. NGUYEN MP, Al-Adli NN, Theodosopoulos PV, Hervey-Jumper SL, et al
    Association of cystic features with more rapid recovery of neurological deficits following resection of brain metastases.
    J Neurosurg. 2025 Dec 12:1-10. doi: 10.3171/2025.7.JNS25241.
    PubMed         Abstract available
    
    

    
    Neuro Oncol

37. HU X, Xiong Y, Villodre ES, Zhang H, et al
    Soluble E-cadherin-CXCL1-CXCR2 Axis as a Therapeutic Vulnerability in Inflammatory Breast Cancer Brain Metastasis.
    Neuro Oncol. 2026 Jan 24:noag012. doi: 10.1093.
    PubMed         Abstract available
    
    
38. KASHIWAGI H, Wanibuchi M, Ikeda N, Nonoguchi N, et al
    Investigator-led clinical trial of boron neutron capture therapy system for recurrent high-grade meningiomas after radiation therapy: Randomized phase II study.
    Neuro Oncol. 2026 Jan 21:noaf279. doi: 10.1093.
    PubMed         Abstract available
    
    

    
    Neuroradiology

39. SUN P, Xie Z, Wang S, Zhang C, et al
    Integrating large language models (LLMs) into neuro-oncologic radiology: a retrospective feasibility assessment of GPT-4o for brain tumor diagnosis.
    Neuroradiology. 2026 Jan 19. doi: 10.1007/s00234-025-03896.
    PubMed        
    
    

    
    Neurosurgery

40. BEKTAS D, Lanzino G, Graepel S, Flemming KD, et al
    Hypertrophic Olivary Degeneration in Brainstem Cavernous Malformations: An Analysis of Predictors and Clinical Implications.
    Neurosurgery. 2025 Jul 17. doi: 10.1227/neu.0000000000003631.
    PubMed         Abstract available
    
    

    
    PLoS Comput Biol

41. CHO H, Lee J, Lawler S, Kim Y, et al
    How do tumor-associated neutrophils regulate the microenvironmental landscape of brain tumors: Delivery of nano-particles through BBB.
    PLoS Comput Biol. 2026;22:e1013906.
    PubMed         Abstract available
    
    
42. MALIK AA, Krona C, Kundu S, Gerlee P, et al
    Anatomically aware simulation of patient-specific glioblastoma xenografts.
    PLoS Comput Biol. 2026;22:e1013831.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Neoplasms of the CNS is free of charge.